South Korea regulates medical devices in four risk classes. Class I is a notification, most Class II devices are certified, and Class III and IV devices — with some Class II — need MFDS approval. An approval from the US or the EU does not shorten that review. Meridian Trace holds 96,000+ South Korea registration records as at 20 October 2026, alongside 30 other markets.
Try it free →The Ministry of Food and Drug Safety (MFDS) regulates medical devices under the Medical Device Act, in force since 30 May 2004, with its Enforcement Decree, its Enforcement Regulations and MFDS notices beneath it. MFDS assigns every device item a class in its regulation on medical device items and grades by item; in vitro diagnostic devices have their own item list.
| Class | Risk level | Examples (MFDS) | Route to market |
|---|---|---|---|
| Class I | Very low | Ophthalmic microscope, operation table, stethoscope | Notification |
| Class II | Low | MRI, pulse oximeter, sterilizer | Certification for devices equivalent to ones already on the market; MFDS approval for new devices |
| Class III | Moderate | Anaesthesia (gas) system, silk suture | MFDS approval |
| Class IV | High | Implantable defibrillator, coronary stent, intraocular lens | MFDS approval |
Some Class I and II devices go to MFDS approval whatever their class: those that need clinical trial reports, digital-healthcare devices such as telemedicine systems, devices with no defined nomenclature and classification, and devices combined with pharmaceuticals.
Clinical trial reports are needed when a device differs from ones already on the market in intended use, mechanism of action or raw materials in ways that could significantly affect safety and efficacy. A device that is substantially equivalent to one already approved, certified or notified goes through technical document review without them.
Two recent changes bear on these routes. Since 30 September 2026 a Class II applicant can file the technical review and the certification in one application, and since 1 June 2026 MFDS has offered a pre-submission meeting and parallel review for innovative devices. Both are on Regulatory changes.
Korea licenses the business as well as the product. A company that manufactures devices in Korea needs a manufacturing business licence; a company that imports them needs an import business licence, issued by the MFDS regional office for its site. An applicant must hold at least one product licence to get the business licence, so the two are processed together.
For an imported device, the product licence is held by the Korean importer. If that importer is your distributor, your Korean licence is in your distributor's name. Decide who holds it before you sign a distribution agreement, not after.
No Korean route shortens the MFDS review because a device is approved in the US or the EU. Two things do carry across:
For how Korea compares with markets that do offer a shortcut, see Your FDA clearance is a shortcut in some markets and a gate in others.
Meridian Trace holds 96,000+ South Korea registration records as at 20 October 2026. Each record:
You can use it to:
Search South Korea medical device registrations
96,000+ records as at 20 October 2026. Try it free for 30 days and we will set it up around your products.
Most companies come to us with one of these four questions. Each one is a conversation, not a form.
96,000+ records in Meridian Trace as at 20 October 2026. See which Korean company holds each licence before you choose a partner.